For example, maternally expressed gene 3 (MEG3) was recently shown to inhibit PDAC proliferation via activation of p53 and to play a key role in the anti-tumor effects of fenofibrate, a PPAR-α agonist62. This evidence concerns the gene PPARA and neoplasm.